Immunotherapy kinder than chemotherapy for patients with head and neck cancer
The immunotherapy nivolumab is kinder than chemotherapy for people with advanced head and neck cancer…
Browsing: NICE
England’s Cancer Drugs Fund ‘failed to deliver meaningful value to patients and society’
Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund…
Non-profit drug development could cut cost of cancer medicines
Universities should work with new forms of commercial partner to take their own cancer drugs…
NICE recommends abiraterone for prostate cancer
NICE has issued final guidance recommending abiraterone (marketed as Zytiga by Janssen) for some prostate…
Health secretary urged to tear up patent on breast cancer drug
By Sarah Boseley – The Guardian (UK Edition). Medics and campaigners call on UK Health Secretary Jeremy…
NICE approves tamoxifen as a preventative in UK – will Australian women be offered this treatment?
New guidance published by NICE a “game changer” for UK women with genetic risk of…